InnovAge (INNV)
(Delayed Data from NSDQ)
$4.04 USD
-0.04 (-0.98%)
Updated May 3, 2024 04:00 PM ET
After-Market: $4.09 +0.05 (1.24%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum D VGM
Brokerage Reports
InnovAge Holding Corp. [INNV]
Reports for Purchase
Showing records 1 - 20 ( 23 total )
Company: InnovAge Holding Corp.
Industry: Medical Services
Optimized Entry and Exit Levels for INNV 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: InnovAge Holding Corp.
Industry: Medical Services
Company: InnovAge Holding Corp.
Industry: Medical - Drugs
Company: InnovAge Holding Corp.
Industry: Medical - Drugs
Operational Momentum Continues Ahead of Merger With Aytu; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: InnovAge Holding Corp.
Industry: Medical - Drugs
Merger With Aytu and 2Q19 Results Show Operations Point in the Right Direction; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: InnovAge Holding Corp.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: InnovAge Holding Corp.
Industry: Medical - Drugs
Demonstrating Capabilities That Mimic the Operations of Major OTC Drug Makers; Initiating Coverage With a Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: InnovAge Holding Corp.
Industry: Medical - Drugs
Company: InnovAge Holding Corp.
Industry: Medical - Drugs
Company: InnovAge Holding Corp.
Industry: Medical - Drugs
Company: InnovAge Holding Corp.
Industry: Medical - Drugs
Company: InnovAge Holding Corp.
Industry: Medical - Drugs
Reported another quarter of record in 2Q18 on August 14, 2018.
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A
Company: InnovAge Holding Corp.
Industry: Medical - Drugs
Company: InnovAge Holding Corp.
Industry: Medical - Drugs
Company: InnovAge Holding Corp.
Industry: Medical - Drugs
Reports positive clinical results for UriVarx® in overactive bladders
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A